Royal College Paediatrics and Child Health 201146

The RCPCH working party has made four key recommendations for healthcare professionals involved the management of children and young people aged 0 to 18 years with anaphylaxis, and the patients/carers themselves:

  1. Prompt administration of adrenaline by intramuscular injection is the cornerstone of therapy both in the hospital and in the community.
  2. Children and young people at risk of anaphylaxis should be referred to clinics with specialist competence in paediatric allergies.
  3. Risk analysis should be performed for all patients with suspected anaphylaxis.
  4. Provision of a management plan may reduce the frequency and severity of further reactions and is a recommended part of anaphylaxis management.


The basic prevention and treatment package should include an adrenaline injector, training for the use of adrenaline injector, basic avoidance advice and patient group information.

MEDA Skyway House, Parsonage Road, Takeley, Bishop’s Stortford CM22 6PU – T +44 (0)845 460 0000 | F +44 (0)845 460 0002 – Email: info@medapharma.co.uk

UK/EPI/11/0059 October 2011